Femtech investment is on the rise again, with 2023 already surpassing last year's total deal value.

This year, $980 million has been invested across 64 deals, compared to $840 million from 94 deals in 2022.

The renewed interest in the sector can be attributed to the US Supreme Court's decision in June 2022 that eliminated the constitutional right to abortion.

Despite legal disputes and a challenging fundraising environment, the femtech sector has seen increased activity.

Notable recent transactions include Flo Health, a reproductive health startup, which raised $200 million in a Series C funding round led by General Atlantic, bringing its valuation to over $1 billion.

Maven, a telehealth platform for women and families, is also in the process of raising over $100 million from StepStone.

These developments indicate a growing confidence among investors in the femtech space.